6-((1S,2S)-1-(dimethylamino)-1-(4-(phenylsulfonyl)phenyl)propan-2-ylamino)-2,4-dimethyl-1,2,4-triazine-3,5(2H,4H)-dione

ID: ALA4088595

PubChem CID: 132153759

Max Phase: Preclinical

Molecular Formula: C22H27N5O4S

Molecular Weight: 457.56

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](Nc1nn(C)c(=O)n(C)c1=O)[C@H](c1ccc(S(=O)(=O)c2ccccc2)cc1)N(C)C

Standard InChI:  InChI=1S/C22H27N5O4S/c1-15(23-20-21(28)26(4)22(29)27(5)24-20)19(25(2)3)16-11-13-18(14-12-16)32(30,31)17-9-7-6-8-10-17/h6-15,19H,1-5H3,(H,23,24)/t15-,19+/m0/s1

Standard InChI Key:  LIBRBDZWCDLREN-HNAYVOBHSA-N

Molfile:  

     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
   15.8816  -22.0559    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4771  -21.3502    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.0681  -22.0533    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.7338  -17.2789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7379  -16.4638    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0380  -16.0550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3295  -16.4568    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3254  -17.2718    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0298  -17.6852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0432  -15.2379    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0269  -18.5023    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3177  -18.9084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3147  -19.7256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6115  -18.4972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6056  -20.1316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0210  -20.1367    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0180  -20.9539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7302  -19.7307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6244  -16.0437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9019  -19.7201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1932  -20.1255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1898  -20.9435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9010  -21.3545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6068  -20.9468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4405  -17.6893    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.4477  -16.0588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7744  -20.9403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7779  -20.1249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0720  -19.7148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3623  -20.1218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3631  -20.9432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0696  -21.3497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  9  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  6 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  6
 13 15  1  1
 13 16  1  0
 16 17  1  0
 16 18  1  0
  7 19  1  0
 15 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 15  1  0
  4 25  2  0
  5 26  1  0
 22  2  1  0
  2 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4088595

    ---

Associated Targets(Human)

KAT2B Tchem Histone acetyltransferase PCAF (884 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 457.56Molecular Weight (Monoisotopic): 457.1784AlogP: 1.42#Rotatable Bonds: 7
Polar Surface Area: 106.30Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.17CX LogP: 2.19CX LogD: 2.16
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.57Np Likeness Score: -0.99

References

1. Humphreys PG, Bamborough P, Chung CW, Craggs PD, Gordon L, Grandi P, Hayhow TG, Hussain J, Jones KL, Lindon M, Michon AM, Renaux JF, Suckling CJ, Tough DF, Prinjha RK..  (2017)  Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe.,  60  (2): [PMID:28002667] [10.1021/acs.jmedchem.6b01566]
2. Moustakim M, Clark PGK, Hay DA, Dixon DJ, Brennan PE..  (2016)  Chemical probes and inhibitors of bromodomains outside the BET family.,  (12): [PMID:29170712] [10.1039/C6MD00373G]
3. Huang L, Li H, Li L, Niu L, Seupel R, Wu C, Cheng W, Chen C, Ding B, Brennan PE, Yang S..  (2019)  Discovery of Pyrrolo[3,2- d]pyrimidin-4-one Derivatives as a New Class of Potent and Cell-Active Inhibitors of P300/CBP-Associated Factor Bromodomain.,  62  (9): [PMID:30998845] [10.1021/acs.jmedchem.9b00096]

Source